As of 2026-09-20, the Relative Valuation of Sigilon Therapeutics, Inc. (SGTX) is (303.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of Sigilon Therapeutics, Inc. based on Relative Valuation is -1451.9%.
The range of the Relative Valuation is (280.18) - (350.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 23.8x | 21.4x |
| Forward P/E multiples | 15.7x - 23.9x | 19.8x |
| Fair Price | (280.18) - (350.97) | (303.78) |
| Upside | -1346.9% - -1661.9% | -1451.9% |
| Date | P/E |